• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • JobWatch
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » NIH Commits to Combating Structural Racism in Biomedical Science

NIH Commits to Combating Structural Racism in Biomedical Science

June 21, 2021

The NIH has come out with a strong commitment to ending structural racism in the biomedical research field, outlining its long-term goals and initial actions in its ongoing push for racial equity.

In a new commentary published in Cell by NIH Director Francis Collins and other officials, the institute reaffirmed that structural racism is a chronic problem that has managed to find its way into biomedical research. The institute noted its diversity and inclusion programs have been “valuable but not sufficient.”

The officials detailed the progress of an ongoing initiative, UNITE, which seeks to identify and address structural racism in the scientific community by increasing inclusivity and diversity, establishing an “equitable and civil culture” in biomedical research and tearing down barriers to racial equity in the biomedical research workforce. The program was established in March, and NIH staff have been engaging in research to identify opportunities, make recommendations and employ strategies that increase the inclusion of minorities.

Efforts thus far include an increase in funding opportunities for projects that look to understand and address the impact of racism and discrimination on minority health and health disparities; expansion of the NIH’s diversity and inclusion programs for hiring senior trial investigators; enhancing recruitment of candidates from underrepresented groups and improving retainment rates for diverse staff; gathering demographic data for staff across all NIH job areas and sharing that information; and evaluating policies and practices that may contribute to perpetuating structural racism.

For example, the institute said it has already met its goal of obtaining support for a grant by the National Institute on Minority Health and Health Disparities centered on the impact of structural racism and discrimination on health equity. It has also completed its target of publishing a request for information on practical and effective ways to improve the racial and ethnic inclusivity and diversity of research-centered environments and staff. An effort to appoint high-level staff members that will work to improve diversity, equity and inclusion at each NIH institute and center is already underway, among other measures, the NIH said.

The NIH has established multiple offices focused on improving diversity, including its recently created Equity Committee, which systematically tracks and measures diversity and inclusion metrics for each NIH institute and center’s intramural research program.

Read the full commentary here: https://bit.ly/3gkUaHZ.

Upcoming Events

  • 24May

    Powering an Effective Oversight Strategy with Clinical and Operational Insights

  • 25May

    2022 WCG Avoca Quality & Innovation Summit: Own the Future

  • 28Jun

    Effective Root Cause Analysis and CAPA Investigations for the Life Sciences

  • 16Oct

    WCG MAGI's Clinical Research Hybrid Conference - 2022 West

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • Protocol-360x240.png

    Avoid Deviations by Making Protocol Review a Team Effort

  • SelectionProcess-360x240.png

    Give Us a Voice: Sites Clamor for a Say on Vendor Selection

  • Convince-360x240.png

    Use Data and Details to Convince Site Leadership to Add Staff

  • AsktheExpertsBadge-360x240.png

    Ask the Experts: Listing Trial Staff and Others on the Statement of Investigator

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell My Personal Information

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2022. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing